TRANSCRIPT drug repurposing dataset

Open data API in a single place

Provided by Zenodo

Get early access to TRANSCRIPT drug repurposing dataset API!

Let us know and we will figure it out for you.

Dataset information

Country of origin
Updated
2023.06.14 00:00
Created
2023.01.01
Available languages
English
Keywords
collaborative filtering, MIT licence, drug repurposing, dataset
Quality scoring

Dataset description

Version 1.0.0 (12/28/2022) This is a drug repurposing dataset under MIT licence, compiled by Dr. Clémence Réda <clemence.reda@uni-rostock.de>, comprising a drug-disease association matrix, and several drug-drug and disease-disease similarity matrices. It only uses transcriptomic data (i.e., gene activity/expression). The sparsity number is the percentage of nonzero values in the association matrix. # drugs | # diseases | Sparsity number | # positive associations | # negative associations | # genes ------- | ---------- | --------------- | ----------------------- | ----------------------- | ------- 871     | 144        | 0.76%           | 773                     | 181                     | 10,811 All drugs (resp., diseases) are associated with a gene expression feature vector of length 10,811 (that is, all drugs and diseases in the feature matrices appear in the association matrix, and vice versa). However, some diseases/drugs are not necessarily involved in negative or positive associations (meaning that all pairs with those items have an association value of 0). ---------- This dataset consists of three .CSV files: * Drug-Disease Association Matrix 1. "ratings_mat.csv" This matrix contains values in {-1,0,1} where -1 stands for a negative association (i.e., the drug failed for some reason to treat the considered disease: e.g., lack of accrual in the associated clinical trial, or proven toxicity), 1 for a positive association (i.e., the drug was shown to treat the disease), and 0 for unknown associated status. The columns are diseases, identified by their MedGen Concept ID, whereas rows are drugs, identified by their DrugBank IDs or PubChem CIDs. * Drug Feature Matrix 1. "items.csv" This matrix has drugs in its columns, identified by their DrugBank IDs or PubChem CIDs, and genes in its rows, identified by their HUGO Gene Symbol. Genewise transcriptomic variation induced by drug treatment, from the CREEDS or the LINCS L1000 databases. * Disease Feature Matrix 1. "users.csv" This matrix has diseases in its columns, identified by their MedGen Concept IDs, and genes in its rows, identified by their HUGO Gene Symbol. Genewise transcriptomic variation induced by the disease, from the CREEDS database. ---------- Further information about the generation of those matrices is available by running the Jupyter notebook TRANSCRIPT_dataset-v1.0.0.ipynb on the following GitHub repository: https://github.com/RECeSS-EU-Project/drug-repurposing-datasets. For any questions, please contact the author at <clemence.reda@uni-rostock.de> or the RECeSS project contributors at <recess-project@proton.me>.
European data infrastructure with broad catalog discovery, free evaluation access and production-grade API options.
190K+
indexed dataset pages
32
countries and EU institutions
2019
API-first since
Free API quota
for evaluation and prototypes
SLA
history and push on production APIs
FAQ

Questions before production use

Practical answers on evaluation, licensing, freshness, versioning and support.

api.store is built and operated by Apitalks s.r.o. Company details and a direct contact path are linked in the footer for vendor checks and procurement review.
Yes. Selected APIs include a free API quota, so your team can validate coverage, freshness, response shape and workflow fit before asking for a production plan.
Often yes, but usage rights depend on the source license and dataset. We surface source, license and update metadata where available, and can help review terms before a production integration.
Maintained APIs include update metadata where available. For production integrations, we can add history, monitoring and push updates so changes are easier to detect and act on.
Production APIs can add SLA, stable identifiers, versioning support, history, push updates and direct support around the data your product or AI workflow depends on.

Didn't find the API you need?

Let us know and we will figure it out for you.

European data discovery with free evaluation access and production-grade API options.

Copyright © 2026. Made by Apitalks